{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:06:47Z","timestamp":1770422807586,"version":"3.49.0"},"reference-count":55,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Biotest AG Dreieich, Germany"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2025,8,4]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe community-acquired pneumonia remains a global health challenge with high mortality despite advances in antibiotic therapy and supportive care. Immunoglobulin therapies, especially IgM-containing ones, have shown promise in enhancing host defence and reducing inflammation. The CIGMA trial highlighted the potential of trimodulin to lower mortality in patients with severe community-acquired pneumonia with high C-reactive protein and low IgM levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the protective effects of trimodulin on clinical status, bacterial burden, lung integrity and inflammatory responses in murine models of lung injury, including both ventilator-induced lung injury and infection-induced models with nonsterile inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In mice, trimodulin significantly protected against lethal pneumococcal pneumonia by reducing bacterial burden and disease severity while preserving alveolar barrier integrity and limiting lung oedema. The antibacterial action of trimodulin was mediated through opsonophagocytosis, and its anti-inflammatory effects operated independently of the latter. When combined with ampicillin, trimodulin exhibited enhanced suppression of inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings in preclinical pneumonia models suggest that trimodulin could be a promising therapy for severe community-acquired pneumonia. We provide evidence that trimodulin enhances host defence, reduces detrimental pulmonary inflammation and barrier dysfunction, and limits pulmonary oedema, which may explain the beneficial effects observed in patients with severe community-acquired pneumonia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.00392-2025","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:35:11Z","timestamp":1757590511000},"page":"2500392","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Trimodulin supports antibacterial defence and restricts inflammation in preclinical pneumonia models"],"prefix":"10.1183","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-3119","authenticated-orcid":false,"given":"Geraldine","family":"Nouailles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Linke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitt","family":"Gutbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8132-7237","authenticated-orcid":false,"given":"Peter","family":"Pennitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1616-4005","authenticated-orcid":false,"given":"Cengiz","family":"Goekeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Kunder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Vo\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-4951","authenticated-orcid":false,"given":"Theresa C.","family":"Br\u00f6mel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Kershaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miha","family":"Milek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim","family":"Farztdinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"M\u00fclleder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Weissm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina C.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayken","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Bohlaender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Beule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim D.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2026020604200477000_67.2.2500392.1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S1473-3099(18)30407-9","article-title":"The global burden of lower respiratory infections: making progress, but we need to do better","volume":"18","author":"Murdoch","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026020604200477000_67.2.2500392.2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026020604200477000_67.2.2500392.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.14796"},{"key":"2026020604200477000_67.2.2500392.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253118"},{"key":"2026020604200477000_67.2.2500392.5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026020604200477000_67.2.2500392.6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40635-023-00569-5","article-title":"Understanding the mechanisms of ventilator-induced lung injury using animal models","volume":"11","author":"Silva","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"2026020604200477000_67.2.2500392.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5143-7"},{"key":"2026020604200477000_67.2.2500392.8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s13054-023-04719-9","article-title":"The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial","volume":"27","author":"Singer","year":"2023","journal-title":"Crit Care"},{"key":"2026020604200477000_67.2.2500392.9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s40001-024-02008-x","article-title":"Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)","volume":"29","author":"Agafina","year":"2024","journal-title":"Eur J Med Res"},{"key":"2026020604200477000_67.2.2500392.10","unstructured":"Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP). NCT05722938. https:\/\/clinicaltrials.gov\/study\/NCT05722938"},{"key":"2026020604200477000_67.2.2500392.11","unstructured":"A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With Severe Community-acquired Pneumonia (sCAP). NCT05722938 . https:\/\/fdaaa.trialstracker.net\/trial\/NCT05722938\/"},{"key":"2026020604200477000_67.2.2500392.12","unstructured":"Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia. NCT05531149. https:\/\/clinicaltrials.gov\/study\/NCT05531149"},{"key":"2026020604200477000_67.2.2500392.13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/aas.12652","article-title":"IgM-enriched solution BT086 improves host defense capacity and energy store preservation in a rabbit model of endotoxemia","volume":"60","author":"Shmygalev","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"2026020604200477000_67.2.2500392.14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/biomedicines9070817","article-title":"The dual role of a polyvalent IgM\/IgA-enriched immunoglobulin preparation in activating and inhibiting the complement system","volume":"9","author":"Schmidt","year":"2021","journal-title":"Biomedicines"},{"key":"2026020604200477000_67.2.2500392.15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700429"},{"key":"2026020604200477000_67.2.2500392.16","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000220496.48295.A9"},{"key":"2026020604200477000_67.2.2500392.17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003143"},{"key":"2026020604200477000_67.2.2500392.18","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003149"},{"key":"2026020604200477000_67.2.2500392.19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s15010-021-01605-w","article-title":"Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade","volume":"49","author":"Braeken","year":"2021","journal-title":"Infection"},{"key":"2026020604200477000_67.2.2500392.20","first-page":"e51174","article-title":"Following in real time the impact of pneumococcal virulence factors in an acute mouse pneumonia model using bioluminescent bacteria","volume":"84","author":"Saleh","year":"2014","journal-title":"J Vis Exp"},{"key":"2026020604200477000_67.2.2500392.21","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0759-2"},{"key":"2026020604200477000_67.2.2500392.22","unstructured":"Taylor A . Experimentelle Untersuchung einer neuartigen adjuvanten Therapie auf Immunglobulinbasis bei schwerer Lungenentz\u00fcndung unter mechanischer Beatmung [Experimental Investigation of a Novel Immunoglobulin-Based Adjuvant Therapy for Severe Pneumonia Under Mechanical Ventilation] [Dissertation]. Berlin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, 2021."},{"key":"2026020604200477000_67.2.2500392.23","unstructured":"Bischoff R . Experimentelle Untersuchungen adjuvanter Therapien bei schwerer Pneumonie und Beatmung [Experimental Studies of Adjuvant Therapies for Severe Pneumonia and Ventilation] [Dissertation]. Berlin, Freie Universit\u00e4t Berlin, 2025."},{"key":"2026020604200477000_67.2.2500392.24","doi-asserted-by":"crossref","unstructured":"Ghetie VWE , Vitetta ES . Pharmacokinetics of antibodies and immunotoxins in mice and humans . In: Figg WD , McLeod HL (eds), Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Totowa, NJ, Humana Press, 2004, pp. 475\u2013498.","DOI":"10.1007\/978-1-59259-734-5_29"},{"key":"2026020604200477000_67.2.2500392.25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2024.02.002","article-title":"Future therapies of hepatic encephalopathy","volume":"28","author":"Buckholz","year":"2024","journal-title":"Clin Liver Dis"},{"key":"2026020604200477000_67.2.2500392.26","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000222"},{"key":"2026020604200477000_67.2.2500392.27","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2009-0210ST"},{"key":"2026020604200477000_67.2.2500392.28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz447"},{"key":"2026020604200477000_67.2.2500392.29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2026020604200477000_67.2.2500392.30","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/biomedicines11113022","article-title":"Multifaceted tissue-protective functions of polyvalent immunoglobulin preparations in severe infections-interactions with neutrophils, complement, and coagulation pathways","volume":"11","author":"Schmidt","year":"2023","journal-title":"Biomedicines"},{"key":"2026020604200477000_67.2.2500392.31","unstructured":"Trimodulin - Biotest. https:\/\/adisinsight.springer.com\/drugs\/800038202 Date last updated: 20 June 2025."},{"key":"2026020604200477000_67.2.2500392.32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1055\/a-1723-1880","article-title":"Polyvalent immunoglobulin preparations inhibit pneumolysin-induced platelet destruction","volume":"122","author":"Wiebe","year":"2022","journal-title":"Thromb Haemost"},{"key":"2026020604200477000_67.2.2500392.33","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1182\/bloodadvances.2020002372","article-title":"Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro","volume":"4","author":"Jahn","year":"2020","journal-title":"Blood Adv"},{"key":"2026020604200477000_67.2.2500392.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07033-8"},{"key":"2026020604200477000_67.2.2500392.35","doi-asserted-by":"publisher","DOI":"10.1186\/cc13830"},{"key":"2026020604200477000_67.2.2500392.36","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/biomedicines9121828","article-title":"The functional role of IgA in the IgM\/IgA-enriched immunoglobulin preparation trimodulin","volume":"9","author":"Bohlander","year":"2021","journal-title":"Biomedicines"},{"key":"2026020604200477000_67.2.2500392.37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.imbio.2017.09.002","article-title":"A double blind randomized experimental study on the use of IgM-enriched polyclonal immunoglobulins in an animal model of pneumonia developing shock","volume":"222","author":"Vaschetto","year":"2017","journal-title":"Immunobiology"},{"key":"2026020604200477000_67.2.2500392.38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1753425919853333","article-title":"The novel polyclonal Ab preparation trimodulin attenuates ex vivo endotoxin-induced immune reactions in early hyperinflammation","volume":"25","author":"Duerr","year":"2019","journal-title":"Innate Immun"},{"key":"2026020604200477000_67.2.2500392.39","first-page":"P197","article-title":"IgM\/IgA-enriched immunoglobulins: more than an IVIg: about multimeric IgA, IgM & J-chain","volume":"26","author":"Bohl\u00e4nder","year":"2022","journal-title":"Crit Care"},{"key":"2026020604200477000_67.2.2500392.40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.ta.0000187797.38327.78","article-title":"Immunoglobulin a modulates inflammatory responses in an in vitro model of pneumonia","volume":"59","author":"Diebel","year":"2005","journal-title":"J Trauma"},{"key":"2026020604200477000_67.2.2500392.41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053238"},{"key":"2026020604200477000_67.2.2500392.42","doi-asserted-by":"crossref","first-page":"1127339","DOI":"10.3389\/fimmu.2023.1127339","article-title":"A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases","volume":"14","author":"Bohlander","year":"2023","journal-title":"Front Immunol"},{"key":"2026020604200477000_67.2.2500392.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(01)00025-6"},{"key":"2026020604200477000_67.2.2500392.44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13613-019-0501-3","article-title":"The clinical efficacy of intravenous IgM-enriched immunoglobulin (Pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis","volume":"9","author":"Cui","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2026020604200477000_67.2.2500392.45","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/jcm9051592","article-title":"Pentaglobin efficacy in reducing the incidence of sepsis and transplant-related mortality in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective study","volume":"9","author":"Carlone","year":"2020","journal-title":"J Clin Med"},{"key":"2026020604200477000_67.2.2500392.46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13613-020-00740-1","article-title":"Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis","volume":"10","author":"Nierhaus","year":"2020","journal-title":"Ann Intensive Care"},{"key":"2026020604200477000_67.2.2500392.47","doi-asserted-by":"crossref","first-page":"1239014","DOI":"10.3389\/fped.2023.1239014","article-title":"Clinical efficacy of IgM-enriched immunoglobulin as adjunctive therapy in neonatal and pediatric sepsis: a systematic review and meta-analysis","volume":"11","author":"Dinleyici","year":"2023","journal-title":"Front Pediatr"},{"key":"2026020604200477000_67.2.2500392.48","doi-asserted-by":"publisher","DOI":"10.1186\/cc9209"},{"key":"2026020604200477000_67.2.2500392.49","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1164\/rccm.202202-0320OC","article-title":"Ventilator-induced lung injury is modulated by the circadian clock","volume":"207","author":"Felten","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020604200477000_67.2.2500392.50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1203954109"},{"key":"2026020604200477000_67.2.2500392.51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2731"},{"key":"2026020604200477000_67.2.2500392.52","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00330.2007"},{"key":"2026020604200477000_67.2.2500392.53","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9086-3_1"},{"key":"2026020604200477000_67.2.2500392.54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41541-023-00715-w","article-title":"Emerging vaccine strategies against the incessant pneumococcal disease","volume":"8","author":"Duke","year":"2023","journal-title":"NPJ Vaccines"},{"key":"2026020604200477000_67.2.2500392.55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188251"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00392-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:20:17Z","timestamp":1770380417000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00392-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,5]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1183\/13993003.00392-2025"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00392-2025","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}